Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 5

1.

Pediatric Dosing and Body Size in Biotherapeutics.

Shi R, Derendorf H.

Pharmaceutics. 2010 Dec 16;2(4):389-418. Review.

2.

Post-HAART outcomes in pediatric populations: comparison of resource-limited and developed countries.

Peacock-Villada E, Richardson BA, John-Stewart GC.

Pediatrics. 2011 Feb;127(2):e423-41. doi: 10.1542/peds.2009-2701. Epub 2011 Jan 24. Review.

3.

Enfuvirtide antiretroviral therapy in HIV-1 infection.

Kitchen CM, Nuño M, Kitchen SG, Krogstad P.

Ther Clin Risk Manag. 2008 Apr;4(2):433-9.

4.

Canadian Consensus Recommendations for the Optimal Use of Enfuvirtide in HIV/AIDS Patients.

Rachlis A, Angel J, Harris M, Lalonde R, Smaill F, Tremblay C, Tsoukas C, Walmsley S.

Can J Infect Dis Med Microbiol. 2006 May;17(3):155-63.

5.

HIV-susceptible transgenic rats allow rapid preclinical testing of antiviral compounds targeting virus entry or reverse transcription.

Goffinet C, Allespach I, Keppler OT.

Proc Natl Acad Sci U S A. 2007 Jan 16;104(3):1015-20. Epub 2007 Jan 5.

Supplemental Content

Support Center